Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Health Tech
Hims & Hers partners with Eli Lilly to sell Zepbound, Foundayo
Hims & Hers struck a deal with Eli Lilly to offer the drugmaker’s branded obesity treatments through its online health and wellness platform.
Heather Landi
Nov 6, 2026 4:30pm
Fierce Pharma
CMS locks in Medicare drug price negotiations for the long haul
Nov 6, 2026 4:24pm
Equiti acquires Lexi AI to expand healthcare language access
Nov 6, 2026 3:00pm
Omada Health hikes 2026 outlook after strong Q3
Nov 6, 2026 3:00pm
Healthcare Dealmakers—Chicago's $11B hospital merger and more
Nov 6, 2026 2:00pm
Mayo Clinic Platform develops AI-driven decision support tool
Nov 6, 2026 1:30pm
More News
Industry Voices—Where healthcare fraud enforcement goes next
Nov 6, 2026 12:59pm
Humana pacing ahead during Medicare enrollment period, CEO says
Nov 6, 2026 11:50am
Court blocks CMS' moratorium on new ACA broker registrations
Nov 5, 2026 4:30pm
Oscar hits $5.1B in Q3 revenue, boosts guidance
Nov 5, 2026 2:35pm